Finding a potential dipeptidyl peptidase-4 (DPP-4) inhibitor for type-2 diabetes treatment based on molecular docking, pharmacophore generation, and molecular dynamics simulation
The benefits of GLP-1 medications go beyond glucose control and supporting weight loss they can also reduce the risk of serious complications like heart disease, kidney disease, and fatty liver disease
Li F, Xu W, Zhao S
DOI: 10.1007/s40200-021-00798-z, Clifford, T., Howatson, G., West, D
GHK-Cu peptide may serve as a biological copper source for copper-dependent enzymes, most notably lysyl oxidase, which catalyzes the crosslinking of collagen fibrils
Zepbound and Mounjaro Redefine Drug Launch Speed in the U.S